Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients [Phase 2]
Phase 2 trial evaluating Oshadi D and Oshadi R combined with salvage chemotherapy in relapsed acute myeloid leukemia and lymphoid leukemia i…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm [NA]
This clinical trial update reports results for using decitabine plus cytarabine in older adults with untreated acute myeloid leukemia, high-…
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies [Phase 2]
A Phase 2 trial evaluated haplotype-mismatched hematopoietic stem cell transplantation in patients with hematological malignancies. The stud…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating trametinib in combination with the AKT inhibitor GSK2141795 for acute myeloid leukemia was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors [NA]
Terminated clinical trial evaluating induction chemotherapy in elderly acute myeloid leukemia patients followed by G-CSF-mobilized haploiden…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan, fludarabine phosphate, and anti-thymocyte globulin followed by donor stem cell …
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial comparing clofarabine plus cytarabine against conventional induction therapy in newly diagnosed acute myeloid leukemia; also s…
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia [Phase 1]
A Phase 1 study examining donor stem cell transplant for high-risk acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 1]
A Phase 1 study evaluating ipilimumab in patients with relapsed or refractory high-risk myelodysplastic syndrome or acute myeloid leukemia h…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [Phase 1]
Phase 1 clinical trial update evaluating mitomycin C and mitoxantrone in patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: 1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML) [Phase 1]
This update notes the completion of a Phase 1 clinical trial evaluating Erwinaze for Acute Myeloid Leukemia.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission [Phase 1]
Phase 1 trial update evaluating a cancer vaccine therapy in combination with Basiliximab for adults with acute myeloid leukemia (in remissio…
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: DCHA as Postremission Therapy for AML With t(8;21) [Phase 1, Phase 2]
A clinical trial update describing Phase 1 and Phase 2 studies of DCHA as postremission therapy for acute myeloid leukemia with t(8;21).
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 trial of intensive chemotherapy with or without volasertib in newly diagnosed high-risk myelodysplastic syndrome and acute myeloid…
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Chidamide Plus DCAG for Relapsed/Refractory AML [Phase 1, Phase 2]
Phase 1/2 trial investigating chidamide in combination with DCAG for relapsed or refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies [Phase 2]
Phase 2 trial of bortezomib plus vorinostat in younger patients with MLL-rearranged hematologic malignancies was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML) [Phase 2]
A Phase 2 trial of venetoclax (ABT-199) in patients with acute myeloid leukemia has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating atorvastatin for prophylaxis of acute graft-versus-host disease in patients undergoing HLA-mon donor hematopoietic …
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT [Phase 2]
Phase 2 trial evaluating post-transplant cyclophosphamide as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: Trial of CPX-351 in Newly Diagnosed Elderly AML Patients [Phase 2]
Phase 2 trial update of CPX-351 in newly diagnosed elderly patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating decitabine followed by mitoxantrone, etoposide, and cytarabine in adults with relapsed/refractory acute …
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients [Phase 2]
Phase 2 trial of haploidentical NK cells with SQ IL-15 in adults with relapsed or refractory acute myeloid leukemia has completed with poste…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety and tolerability of the combination of voreloxin and cytarabine in adults with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML [Phase 1, Phase 2]
Phase I/II dose-escalation trial evaluating lovastatin with high-dose cytarabine for refractory or relapsed acute myeloid leukemia; study TE…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations [Phase 2]
Phase 2 clinical trial update investigating a regimen of decitabine, cytarabine, and arsenic trioxide for acute myeloid leukemia with p53 mu…